Arkolith/Insider Trading/LCTX/Form 4

Mulroy Michael H.

DirectorLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Nov 25, 2024
Net Buying
Open-Market Buys
$23K
Open-Market Sells
$0
Net Open-Market Flow
$23K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2024Buy(P)40K$0.57$23K299K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-130592) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML